ATORVASTATIN CALCIUM
NDC 82009-176, ATORVASTATIN CALCIUM, tablet, film coated, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-176
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214344
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-176 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATORVASTATIN CALCIUM TRIHYDRATE10 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-176-10 | 82009017610 | 1000 TABLET, FILM COATED in 1 BOTTLE (82009-176-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5b94b6f4-6f64-4551-abcb-8e845fb13813NADAC price for package 82009017610
GET /v1/drugs/nadac/82009017610
Use it
Look up 82009-176 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-176 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-176. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.